1Cademy - Harmful ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection

Learn Before

Using ACE Inhibitors (ACE-Is) to Treat or Prevent COVID-19
Using Angiotensin Receptor Blockers (ARBs) to Treat or Prevent COVID-19

Concept

"Harmful" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection

Some believe that ACE-I/ARB use is harmful in treating SARS-CoV-2 infections because they increase the expression of ACE2, allowing the virus more opportunity to enter host cells.

Updated 2021-02-28

Contributors are:

Who are from:

Michigan State University

🏆 3

Smith College

✔️ 1

References

Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France

Learn After

Findings that support the "harmful" ACE-I/ARB hypothesis

Learn Before

Related

Learn After